Guy E. Padbury

463 total citations
15 papers, 276 citations indexed

About

Guy E. Padbury is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Guy E. Padbury has authored 15 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Infectious Diseases. Recurrent topics in Guy E. Padbury's work include Drug Transport and Resistance Mechanisms (4 papers), HIV/AIDS drug development and treatment (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Guy E. Padbury is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), HIV/AIDS drug development and treatment (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Guy E. Padbury collaborates with scholars based in United States, Netherlands and Norway. Guy E. Padbury's co-authors include Stephen G. Sligar, Barry S. Lutzke, Geri A. Sawada, Thomas J. Raub, Tanya L. Wallace, Gary L. Petzold, T F Dekoning, William C. Krueger, Michael Houghton and Mark D. Prairie and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Guy E. Padbury

15 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guy E. Padbury United States	7	144	84	77	23	22	15	276
David L. Musso United States	11	136 0.9×	47 0.6×	145 1.9×	19 0.8×	5 0.2×	22	330
Madeleine Blanc France	11	172 1.2×	100 1.2×	179 2.3×	14 0.6×	42 1.9×	18	438
Víctor Mangas‐Sanjuan Spain	15	144 1.0×	180 2.1×	95 1.2×	28 1.2×	8 0.4×	26	478
R. Battaglia Italy	11	93 0.6×	71 0.8×	78 1.0×	57 2.5×	6 0.3×	26	333
Malini Dasgupta United States	9	134 0.9×	39 0.5×	80 1.0×	24 1.0×	10 0.5×	13	317
Xiao-Dong Qian China	8	194 1.3×	142 1.7×	84 1.1×	17 0.7×	8 0.4×	11	345
Daniele Pezzetta Italy	7	137 1.0×	120 1.4×	59 0.8×	32 1.4×	5 0.2×	10	282
Frederick Wong United States	11	212 1.5×	53 0.6×	179 2.3×	9 0.4×	6 0.3×	18	456
Katja Stefan Germany	11	165 1.1×	185 2.2×	105 1.4×	12 0.5×	7 0.3×	13	366
Grant Wishart United Kingdom	13	397 2.8×	68 0.8×	218 2.8×	24 1.0×	7 0.3×	29	633

Countries citing papers authored by Guy E. Padbury

Since Specialization

Citations

This map shows the geographic impact of Guy E. Padbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy E. Padbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy E. Padbury more than expected).

Fields of papers citing papers by Guy E. Padbury

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy E. Padbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy E. Padbury. The network helps show where Guy E. Padbury may publish in the future.

Co-authorship network of co-authors of Guy E. Padbury

This figure shows the co-authorship network connecting the top 25 collaborators of Guy E. Padbury. A scholar is included among the top collaborators of Guy E. Padbury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy E. Padbury. Guy E. Padbury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Thway, Theingi M., et al.. (2011). Model-based strategy for bioanalytical method comparison: Measurement of a soluble ligand as a biomarker. Journal of Pharmaceutical and Biomedical Analysis. 58. 65–70. 3 indexed citations

Padbury, Guy E., Francis J. Schwende, Zhiyang Zhao, et al.. (2006). Factors Impacting the Delivery of Therapeutic Levels of Pyrone-Based HIV Protease Inhibitors. Kluwer Academic Publishers eBooks. 11. 211–232. 1 indexed citations

Koeplinger, Kenneth A., Thomas J. Raub, Guy E. Padbury, & Zhiyang Zhao. (1999). Equilibrium distribution of HIV antiviral drugs into human peripheral blood mononuclear cells (PBMC) is controlled by free drug concentration in the extracellular medium. Journal of Pharmaceutical and Biomedical Analysis. 19(3-4). 399–411. 8 indexed citations

Sawada, Geri A., Craig L. Barsuhn, Barry S. Lutzke, et al.. (1999). Increased Lipophilicity and Subsequent Cell Partitioning Decrease Passive Transcellular Diffusion of Novel, Highly Lipophilic Antioxidants. Journal of Pharmacology and Experimental Therapeutics. 288(3). 1317–1326. 54 indexed citations

Zhong, Wei-Zhu, Marta G. Williams, Marie T. Borin, & Guy E. Padbury. (1998). Species-dependent enantioselective pharmacokinetics of PNU-103017, a Pyrone HIV protease inhibitor. Chirality. 10(3). 210–216. 2 indexed citations

Hall, Edward D., Paula K. Andrus, Sarah L. Smith, et al.. (1997). Pyrrolopyrimidines: Novel Brain-Penetrating Antioxidants with Neuroprotective Activity in Brain Injury and Ischemia Models. Journal of Pharmacology and Experimental Therapeutics. 281(2). 895–904. 58 indexed citations

Zhao, Zhiyang, Kenneth A. Koeplinger, Guy E. Padbury, et al.. (1997). Contribution of serum protein association to discrepancy between the in vivo and in vitro UDS results for 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-d]pyrimidine (U-89843). Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 395(2-3). 119–126. 3 indexed citations

Schwartz, Theresa, Gordon L. Bundy, Joseph W. Strohbach, et al.. (1997). Synthesis and pharmacological evaluation of sulfone substituted HIV protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 7(4). 399–402. 2 indexed citations

Bundy, Gordon L., Donald E. Ayer, Lee S. Banitt, et al.. (1996). ChemInform Abstract: Synthesis of Novel 2,4‐Diaminopyrrolo(2,3‐d)pyrimidines with Antioxidant, Neuroprotective, and Antiasthma Activity.. ChemInform. 27(7). 2 indexed citations

10.

Koeplinger, Kenneth A., Gordon L. Bundy, Lee S. Banitt, et al.. (1996). In vitro and in vivo biotransformation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-D]pyrimidine (U-89843) in the rat.. Drug Metabolism and Disposition. 24(2). 187–198. 3 indexed citations

11.

Zhao, Zhiyang, Kenneth A. Koeplinger, Guy E. Padbury, et al.. (1996). Bioactivation of 6,7-Dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-d]pyrimidine (U-89843) to Reactive Intermediates That Bind Covalently to Macromolecules and Produce Genotoxicity¹. Chemical Research in Toxicology. 9(8). 1230–1239. 8 indexed citations

12.

Tellingen, Olaf van, et al.. (1994). Fully automated high-performance liquid chromatographic method for the determination of carzelesin (U-80,244) and metabolites (U-76,073 and U-76,074) in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 652(1). 51–58. 4 indexed citations

13.

Dekoning, T F, Robert C. Kelly, William C. Krueger, et al.. (1992). Cytotoxicity and antitumor activity of carzelesin, a prodrug cyclopropylpyrroloindole analogue.. PubMed. 52(18). 4904–13. 81 indexed citations

14.

Padbury, Guy E., et al.. (1988). Ferric bleomycin catalyzed reduction of 10-hydroperoxy-8,12-octadecadienoic acid: evidence for homolytic oxygen-oxygen bond scission. Biochemistry. 27(20). 7846–7852. 25 indexed citations

15.

Padbury, Guy E. & Stephen G. Sligar. (1985). Chemical reactivities of bleomycin.. Journal of Biological Chemistry. 260(13). 7820–7823. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact